|
Documenting Results
LDR’s reputation escalated as word
of its new developments and strong
clinical performances in Europe
circulated. Demonstrating this strong
clinical performance is critical to the
ongoing success of LDR’s products.
• Since 2004, a prospective trial has
been ongoing in Europe that pools
data from 9 evaluating centers to
assess the safety and efficacy of
the Mobi-C in treating cervical
degenerative disease.
• Since 2003, a similar study is in progress for Mobidisc
in treating lumbar degenerative disease.
• In 2006, LDR was the first company to obtain FDA
approval to conduct an IDE study for the Mobi-C for both one and
two levels in the United States.
• LDR is committed to helping surgeons, through national
or international publications, to continually inform the
worldwide community about our clinical results.
International Training
LDR created a well-organized and utilized international training
program where interested doctors from all over the world are
brought to the experts in their home country. In this hands-on
learning environment, the expert surgeon can share their
experience and surgical technique with maximum effectiveness.
LDR also regularly engages leading surgeons to review clinical
results, assess the product performance, and make suggestions on
how to improve the surgical techniques.
|
Home
Careers
